David Anderson
Chief Tech/Sci/R&D Officer at VBI VACCINES INC.
Net worth: 2 979 $ as of 2024-03-30
Profile
David Evander Anderson was the founder of Variation Biotechnologies (US), Inc. founded in 2001 where he held the title of Vice President-Immunology & Research.
He is also the founder of Variation Biotechnologies, Inc. (Canada).
Currently, Dr. Anderson holds the position of Chief Scientific Officer at VBI Vaccines, Inc. since 2016 and at VBI Vaccines (Delaware), Inc. since 2015.
Previously, he worked as an Assistant Professor at Harvard Medical School in 2009 and as the Chief Scientific Officer & Senior VP-Research at VBI Vaccines, Inc. Dr. Anderson received his doctorate degree from Harvard University in 1999 and his undergraduate degree from the University of California, Davis.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VBI VACCINES, INC.
0.02% | 2023-07-26 | 4,940 ( 0.02% ) | 2 979 $ | 2024-03-30 |
David Anderson active positions
| Companies | Position | Start |
|---|---|---|
| VBI VACCINES INC. | Chief Tech/Sci/R&D Officer | 2016-05-05 |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Chief Tech/Sci/R&D Officer | 2015-07-31 |
Former positions of David Anderson
| Companies | Position | End |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | 2009-01-31 |
Variation Biotechnologies, Inc. (Canada)
 Variation Biotechnologies, Inc. (Canada) BiotechnologyHealth Technology Variation Biotechnologies, Inc. (Canada) is a Canadian company that was founded by David Evander Anderson and is part of VBI Vaccines, Inc. The private company is based in Ottawa, Canada and engages in the manufacture of vaccines. | Founder | - |
| VBI VACCINES INC | Chief Tech/Sci/R&D Officer | - |
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Founder | - |
Training of David Anderson
| Harvard University | Doctorate Degree |
| University of California, Davis | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VBI VACCINES INC. | Health Technology |
| Private companies | 4 |
|---|---|
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Health Technology |
Variation Biotechnologies, Inc. (Canada)
Variation Biotechnologies, Inc. (Canada) BiotechnologyHealth Technology Variation Biotechnologies, Inc. (Canada) is a Canadian company that was founded by David Evander Anderson and is part of VBI Vaccines, Inc. The private company is based in Ottawa, Canada and engages in the manufacture of vaccines. | Health Technology |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Health Technology |
VBI Vaccines, Inc. /Old/
 VBI Vaccines, Inc. /Old/ BiotechnologyHealth Technology VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- David Anderson
